New Data Shows Pfizer’s COVID Pill Highly Effective

NBC News reports:

Additional data from Pfizer’s clinical trial of its oral Covid-19 antiviral drug confirm the treatment’s high level of effectiveness, the company said in a news release Tuesday.

In the final analysis of its Phase 2/3 clinical trial, the antiviral, called Paxlovid, was found to be 89 percent effective at preventing high-risk people from being hospitalized or dying from Covid, the company said.

Experts say an antiviral pill for Covid would have a major impact on the pandemic by making treatment available at home. Current treatments are available only by injection or IV.

Read the full article.